Clinical Trials Browser

Ovarian Neoplasms × navitoclax × Clear all

NCT05358639 2024-11-18

Combination of Olaparib and Navitoclax in Women with HGSC and TNBC

Phase 1 Active not recruiting

BreastGynecologic

Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT02591095 2019-03-19

MONAVI-1

Phase 2 Completed

Ovarian Neoplasms